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This Special Issue of the North American Actuarial Journal contains 14 contributions to 
the academic literature all dealing with longevity risk and capital markets. Draft versions 
of the papers were presented at Longevity 12: The Twelfth International Longevity Risk 
and Capital Markets Solutions Conference that was held in Chicago on 29-30 September 
2016. It was hosted by the Society of Actuaries (SOA) and the Pensions Institute.  
 
Longevity risk and related capital market solutions have grown increasingly important in 
recent years, both in academic research and in the markets we refer to as the new Life 
Market, i.e., the capital market that trades longevity-linked assets and liabilities. Mortality 
improvements around the world are putting more and more pressure on governments, 
pension funds, life insurance companies, as well as individuals, to deal with the longevity 
risk they face. At the same time, capital markets can, in principle, provide vehicles to hedge 
longevity risk effectively and transfer the risk from those unwilling or unable to manage it 
to those willing to invest in this risk in exchange for appropriate risk-adjusted returns or to 
those who have a counterpoising risk that longevity risk can hedge, e.g., life offices and 
reinsurers with mortality risk on their books. Many new investment products have been 
created both by the insurance/reinsurance industry and by the capital markets. Mortality 
catastrophe bonds are an example of a successful insurance-linked security. Some new 
innovative capital market solutions for transferring longevity risk include longevity (or 
survivor) bonds, longevity (or survivor) swaps and mortality (or q-) forward contracts. The 
aim of the International Longevity Risk and Capital Markets Solutions Conferences is to 
bring together academics and practitioners from all over the world to discuss and analyze 
these exciting new developments.  
 
As with the previous conferences, Longevity 12 consisted of both academic papers and 
more practical and policy-oriented presentations. There were four plenary sessions: The 
Demographics of Longevity Risk, Product Innovation, Data Reliability Challenges and 
Timeliness, and Mortality Forecasting in Practice. The following keynote speakers 
presented at these sessions:  
 
                                                 
+ David Blake [D.Blake@city.ac.uk] is Professor of Pension Economics and Director of the Pensions 
Institute, Cass Business School, City University of London, United Kingdom. Richard MacMinn is Visiting 
Fellow at the University of Texas, United States and National Chengchi University, Taiwan 
[richard@macminn.org]. David Blake and Richard MacMinn are Co-Founders of the Longevity Risk and 
Capital Markets Solutions Conferences. They are extremely grateful to Dale Hall and his staff at the Society 
of Actuaries for their superb organization of the conference. 
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• Jay Olshansky (University of Illinois at Chicago) discussed "The Rise and Fall of 
Human Longevity in the 21st Century" and asked the question: “Can we really add 
decades of life to people aged 70+ today faster than we added decades of life to 
children born in the early 20th century?”. His answer was “no”, in large part due to 
the global obesity pandemic. 
• Aubrey de Grey (Chief Science Officer of SENS Research Foundation) spoke about 
“Longevity Escape Velocity: Incorporating Technological Progress into 
Extrapolation”. He argued that ageing is the accrual of living-derived damage and 
that damage can foreseeably be repaired using rejuvenation biotechnology. 
• Sam Gutterman (Retired Director and Consulting Actuary, 
PricewaterhouseCoopers) discussed “Longevity – The Dark Side”. He explained 
that recently in the U.S., there has been a slowdown in mortality reductions and that 
previous improvement in cardiovascular disease mortality will be hard to duplicate 
in future. 
• Vladimir Canudas-Romo (Max Planck Odense Centre on the Biodemography of 
Aging, University of Southern Denmark) presented on “The Past and Future Rise 
of Human Longevity”. He used three models to show that U.S. life expectancy 
continues to increase. Further, new cohorts had higher education and this is 
generally associated with higher life expectancy. 
• Richard L. Sandor (Founder of the Chicago Climate Exchange) gave a talk on 
“Financial Innovation” and explained that keeping regulators in the loop was one 
of the most important factors determining the success of a new market. 
• Amy Kessler (Prudential Financial, Inc.) discussed “New Solutions to an Age-Old 
Problem: Innovative Strategies for Managing Pension and Longevity Risk”. She 
described how the last decade had seen the spread of U.K. de-risking techniques to 
other countries, and this had brought both customization and increased capacity. 
Although many problems had been solved, there was more work to do, such as 
helping pension funds start on the road to de-risking, despite the environment of 
low interest rates, bringing de-risking to more countries, and introducing risk 
transfer solutions for Dutch-style collective DC plans. 
• Laura Hardy (RGA Life Reinsurance Company) spoke about “Longevity Risk 
Transfer: Where does the Market Turn when all the Cheap Capacity is Gone?”. She 
explained how the growth in capacity the U.K. longevity de-risking market was 
explained, in part, by international, mainly U.S., insurers seeking a hedge for their 
own mortality risk exposure. But the capacity generated from the global mortality 
market could only support a fraction of total U.K. longevity exposure. She pointed 
to the following barriers to low-cost capital markets capacity: the tenor of the 
exposure is too high, the exposure is uncapped, and there is also poor pricing 
transparency, volatility, and the impact of medical advances. Laura offered the 
following solutions for bridging the gap: greater use of insurers to help share the 
risk (e.g., via fixed term annuities, tontines, high retentions), greater use of capital 
markets to hedge the risk (e.g., by combining with other risks/blocks and making 
use of a published national longevity index) and using reinsurers to limit the risk 
(e.g., via fixed-term swaps, out-of-the money swaps, and top slicing). 
• Vladimir Nicenko (Willkie Farr & Gallagher), Nicholas Bugler (Wilkie Farr & 
Gallagher), Amy Kessler (Prudential Financial, Inc.) and Chip Gillis (Athene Life 
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Re) gave a presentation entitled “Sidecars: Alternative Capital or Reinsurance?”. 
They explained that sidecars were special purpose reinsurance vehicles with the 
following properties: short duration (2-3 years); capitalized by specialist insurance 
funds, usually by preference shares, though sometimes in the form of debt 
instruments; reinsured a defined pre-agreed book of business or categories of risk; 
have liability limited to the assets of the special purpose vehicle (SPV); and are 
unrated. They are attractive for insurers because they provide: insurers with 
protection against peak risks, additional capacity without the need for permanent 
capital, and an additional source of income by leveraging underwriting expertise. 
They are attractive for investors because they: provide targeted non-correlated 
returns relating to specific risks, are short-tail in nature with an agreed procedure 
for exiting, take advantage of price hikes, and involve no legacy issues that could 
affect an investment in a typical insurer. This, of course, involves challenges when 
it comes to using sidecars in the life sector: which is long term in nature, in contrast 
with investors’ short term horizons; which brings regulatory requirements on 
ceding insurers impacting their ability to generate a return; which requires prudent 
collateral; where the underlying assets of the SPV must generate matching cash 
flows; which must involve true “risk-transfer” for the cedants to attract capital 
relief; which require a financially strong custodian/trustee; and where investor exit 
is not easy due to lack of liquidity.  
• Magali Barbieri (Associate Director, Human Mortality Database) discussed "Data 
Quality Issues and Adjustments in the Human Mortality Database (HMD)". The 
HMD is one of the most widely used databases in global longevity risk transfer, so 
it is important to understand the data challenges involved in running the HMD. 
These include: the availability and timeliness of input data, the granularity of 
available data (e.g., by single year, 5-year or 10-year age grouping), changes in 
definition over time (e.g., the definition of a live birth), and the reliability of the 
information provided (e.g., under-registration (births, deaths, population), 
unknown age or age misstatement). 
• Steve Goss (Social Security Administration) spoke about “The Importance of 
Consistent Data on Deaths and Exposure over Time, by Age, Sex, and Cause of 
Death” and the implications for Social Security, Medicare and other 
insurance/benefit plans in the U.S. 
• Tom Jones (Prudential Financial, Inc.) presented on "The Importance of High 
Quality Data for Underwriting Pension Risk Transfer (PRT) and Longevity 
Reinsurance Transactions (LRTs): An Insurance Company Perspective". He said 
that the quality of mortality and marital data is critical for accurately assessing the 
value of liabilities. For a PRT transaction, where there is a single premium paid 
upfront, the assumption set applies for the next 30-50 years and hence it becomes 
paramount to get accurate data. The marital assumption and the spousal benefit on 
the primary participant’s date of death are critical assumptions for LRTs. They lead 
to huge tail risk in the liability and most of the data sources on the marital 
assumption do not capture “young spousal risk” (as a result of death bed marriages).  
• Karen P. Glenn (Social Security Administration) discussed “Projecting Mortality 
by Age and Cause: The Importance of Data Source, Expert Judgment, and 
Unknown Future Challenges”. She explained how the SSA assumes that mortality 
 4 
 
 
will continue to decline in the future, but it is the rate of decline that is in question. 
The SOA uses three sets of projections (intermediate, low cost, and high cost) 
which depend, in part, on expert judgment. 
• Laurence Pinzur (Aon Hewitt) discussed “The Continuing Evolution of the 
Retirement Plans Experience Committee’s (RPEC’s) Mortality Projection 
Methodology”. The U.S. RPEC model is based on the same conceptual 
underpinnings as the U.K.’s CMI (Continuous Mortality Investigation) model. 
Prior to 2009, RPEC was primarily interested in developing tables of base mortality 
rates for retirement-related applications in the U.S. However, the Mortality 
Improvement (MI) subcommittee of RPEC has been very busy since 2009. RPEC 
assumes that recently observed experience is the best predictor of future near-term 
mortality improvement rates, while long-term rates of mortality improvement are 
based on “expert opinion” and the analysis of longer-term mortality patterns.  
• Vladimir Canudas-Romo gave a second presentation, this time on “Mortality 
Expectations by Cause through 2040: Johns Hopkins Clinicians and Researchers”. 
The presentation described a study that used expert opinion to estimate likely 
changes in the prevention and treatment of important disease conditions and how 
they will affect future life expectancy. Focus groups were held including clinical 
and public health faculty with expertise in the six leading causes of death in the 
U.S. Mortality rates and life tables for 2040 were derived by sex and age. Life 
expectancy at age 20 and 65 was compared to figures published by the SSA and to 
estimates from the Lee-Carter method. There was agreement among all three 
approaches that life expectancy at age 20 will increase by approximately one year 
per decade for females and males between now and 2040. According to the clinical 
experts, 70% of the improvement in life expectancy will occur in cardiovascular 
disease and cancer, while in the last 30 years, most of the improvement has occurred 
in cardiovascular disease. Expert opinion suggests that most of the increase in life 
expectancy will be attributable to the already achieved reduction in smoking rates, 
especially for women. 
• Jay Olshansky also gave a second talk, this time on “Understanding Biology: Going 
Beyond Simple Statistical Extrapolation”. He explained some key common sense, 
biological and demographic rules that are bent or broken by assuming linear 
increases in life expectancy: Rule # 1, linear extrapolations of biological 
phenomenon are inherently dangerous; Rule # 2, aging gets in the way; Rule # 3, 
life expectancy is an inherently bad metric to forecast; and Rule # 4, Zeno’s Paradox 
of Immortality, a classic example of this being the statement that death rates can 
forever decline by half, on the grounds that there is no lower bound on death rates 
other than zero. 
• Finally, Steve Goss spoke about “Projecting Mortality, Different Models for 
Different Purposes and Views About the Future”. He discussed projections based 
on data (i.e., extrapolating past trends) and projections by age, sex, and cause. He 
also considered what future conditions might change, e.g., a decline in female 
smoking, a continued increase in obesity, and a deceleration in health spending, 
especially in the U.S. 
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The academic papers that were selected by us as the editors of this Special Issue went 
through a refereeing process subject to the usual high standards the North American 
Actuarial Journal. They cover the following themes: developing the longevity risk transfer 
market, longevity risk hedging, longevity risk in insurance policies and annuities, the role 
of annuities in portfolios and long-term care solutions, age/period/cohort mortality models, 
and improving mortality estimates using fertility data. We briefly discuss each of the 14 
papers selected.   
 
In “New solutions to an age-old problem: Innovative strategies for managing pension and 
longevity risk”, Amy Kessler points out that, while the pension and longevity risk transfer 
market is barely a decade old, over $360 billion USD in global transactions have already 
taken place, mainly in the United Kingdom, the United States, Canada and the Netherlands. 
The main deals have been buy-outs, buy-ins and longevity swaps for pension plans. Similar 
de-risking solutions have spread to the market for insured annuities. She argues that 
transactions must be simplified, standardized and made available to all pension plans, 
regardless of size. They must also cover younger deferred plan participants, as well as those 
in collective plans where inter-generational risks are important. New investors must be 
brought in and one way of doing this is via sidecars. Capital relief is important in reducing 
the costs of insurance-based solutions, such as those involving tail-risk protection. 
Regulators need to become more comfortable with such deals. 
 
Nicholas Bugler, Kirsty Maclean, Vladimir Nicenko, and Patrick Tedesco write about “Re-
insurance side-cars: The next stage in the development of the longevity risk transfer 
market”. Transaction structures involving reinsurance sidecars can be adapted to benefit 
cedants and sponsoring reinsurers and also to attract a broader spectrum of investors and 
participants by reducing the long-tail risk inherent in longevity risk transfer. While several 
transaction structures are possible, each would fundamentally provide additional capital to 
support transactions in a form that is not subject to a requirement to hold a regulatory 
solvency capital buffer, thereby enabling sponsoring reinsurers to offer keener pricing to 
cedants. As a result, an EU-based cedant could gain considerable capital benefits by 
reinsuring longevity risk, market risk or both to a reinsurance sidecar.   
 
In “Optimal longevity risk transfer and investment strategies”, Samuel H. Cox, Yijia Lin 
and Sheen Liu recognize that there has been a surge of activities in recent years by defined 
benefit (DB) plan sponsors to transfer their pension risk through strategies such as buy-ins 
and buy-outs. As buy-in and buy-out transaction pipelines grow, insurers actively 
participating in the buy-in and buy-out markets are exposed to significant longevity risk 
embedded in pension plans. In this paper, the authors investigate how to maximize a bulk 
annuity insurer’s value with reinsurance and/or longevity securities, subject to constraints 
that control longevity and investment risks as well as overall risk. They apply duality and 
the martingale approach to derive an optimal longevity risk transfer strategy. The results 
show that longevity risk transfer interacts with an insurer’s investment decision for value 
maximization. The analysis also highlights the interdependence of different longevity risk 
management tools to achieve an overall risk target. 
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In “Longevity Greeks: What do insurers and capital market investors need to know?”, 
Kenneth Q. Zhou and Johnny S.-H. Li argue that there is a role for the capital markets in 
sharing some of the huge longevity risk exposures borne by the pension and life insurance 
industries. The transfer of risk can be accomplished by trading standardized derivatives 
such as q-forwards that are linked to published mortality indexes. To strategize such trades, 
it is possible to utilize “longevity Greeks”, which are analogous to equity Greeks that have 
been used extensively in managing stock price risk. The authors derive three important 
longevity Greeks – delta, gamma and vega – on the basis of an extended version of the 
Lee-Carter model that incorporates stochastic volatility. They then study the properties of 
each longevity Greek, and estimate the levels of effectiveness that different longevity 
Greek hedges can possibly achieve. The results reveal several interesting facts; for 
example, in a delta-vega hedge formed by q-forwards, the choice of reference ages does 
not materially affect hedge effectiveness, but the choice of times-to-maturity does. These 
observations may help insurers to better formulate their hedge portfolios, and issuers of 
mortality-linked securities to determine what security structures are more likely to attract 
liquidity. 
 
Andrew J.G. Cairns and Ghali El Boukfaoui write about “Basis risk in index based 
longevity hedges: A guide for longevity hedgers”. They undertake an assessment of 
longevity basis risk in the context of a general index-based hedge. They develop a detailed 
framework for measuring the impact of a hedge on regulatory or economic capital that 
takes population basis risk explicitly into account. The framework is set up in a way that 
accommodates a variety of regulatory regimes such as Solvency II as well as local actuarial 
practice, attempting, therefore, to bridge the gap between academia and practice. This is 
followed by a detailed analysis of the capital relief resulting from a hedge that uses a call 
spread as the hedging instrument. The authors find that the impact of population basis risk 
on capital relief (expressed in terms of a “haircut” (i.e., the reduction in regulatory capital) 
relative to the case with no population basis risk) depends strongly on the exhaustion point 
of the hedge instrument. In particular, in a Solvency II setting, if the exhaustion point lies 
well below the 99.5% Value-at-Risk, population basis risk has negligible impact and the 
haircut is zero. 
 
In “Mortality risk management under the factor copula framework - with applications to 
insurance policy pools”, Ming-Hua Hsieh, Jason C. Tsai, and Jennifer L. Wang point out 
that mortality risk is one of the core risks that life insurers face. The uncertain future 
lifetime of each insured represents one risk factor, and the dependence structure among 
these risk factors determines the aggregate risk of an insurance policy pool. The authors 
use factor copulas to describe the dependence structure among the future lifetimes of 
numerous insureds. To mitigate the systematic mortality risk associated with an insurance 
pool, the insurer may purchase an asset exposed to similar systematic risk. The authors set 
up a two-factor copula framework and solve for the optimal investment amount in the asset. 
In numerical illustrations, they employ real-case data from a life insurer and a life 
settlement market maker involving hundreds of policies. 
 
In “Understanding patterns of mortality homogeneity and heterogeneity across countries 
and their role in modelling mortality dynamics and hedging longevity risk”, Sharon S. 
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Yang, Yu-Yun Yeh, Jack C. Yue, and Hong Chih Huang argue that understanding patterns 
of mortality homogeneity and heterogeneity across countries can assist in modelling 
mortality dynamics and in hedging longevity risk. This study proposes a methodology, 
based on the graduation method, to detect differences in mortality rates across different 
populations. Using an index based on the Partial Standard Mortality Ratio, the authors 
measure mortality homogeneity and heterogeneity, then conduct an empirical study across 
countries with emerging and developed markets. The results of model fitting show that it 
is inappropriate to use a coherent mortality model for the mortality-heterogeneous 
populations. In an application, the authors demonstrate that a reinsurer can utilize 
information concerning mortality homogeneity/heterogeneity for pooling risk in its books 
of life insurance and annuity businesses and increase overall hedge effectiveness. The 
coherent mortality model can help reduce the volatility of the reinsurer’s profit and help 
the reinsurer diversify its longevity risk across homogeneous populations. 
 
Qiheng Guo and Daniel Bauer write about “Different shades of risk: Mortality trends 
implied by term insurance prices”. To infer forward-looking, market-based mortality 
trends, the authors estimate a flexible affine stochastic mortality model based on a set of 
US term life insurance prices using a generalized method of moments approach. They find 
that neither mortality shocks nor stochasticity in the aggregate trend seem to affect the 
prices. In contrast, allowing for heterogeneity in the mortality rates across carriers is 
crucial. The authors conclude that for life insurance, rather than aggregate mortality risk, 
the key risks emanate from the composition of the portfolio of policyholders. These 
findings have consequences for mortality risk management and emphasize important 
directions of mortality-related actuarial research. 
 
In “Hedging annuity risks with the age-period-cohort two-population gravity model”, 
Kevin Dowd, Andrew J.G. Cairns, and David Blake consider the effectiveness of an 
illustrative annuity hedging problem in which a forward annuity predicated on one 
population is hedged by a position in a forward annuity predicated on another population. 
Their analysis makes use of the age-period-cohort two-population gravity model that takes 
account of the observed inter-dependence between the two populations’ mortality rates; it 
also considers the implications of parameter uncertainty, individual death or Poisson risk 
and interest-rate risk for hedge effectiveness. The authors consider horizons of up to 20 
years. For the most part, the results are robust and indicate strong hedge effectiveness, with 
estimates of relative risk reduction varying from about 0.70 in the least effective case to 
well over 0.95 in the most effective cases. 
 
Ralph Rogalla writes about “Optimal portfolio choice in retirement with participating life 
annuities”. He derives optimal consumption, investment, and annuitization patterns for 
retired households that have access to German-style participating payout life annuities 
(PLAs), allowing for capital market risks as well as idiosyncratic and systematic longevity 
risks. PLAs provide guaranteed minimum benefits in combination with participation in 
insurers’ surpluses. Minimum benefits are calculated based on conservative assumptions 
regarding capital market and mortality developments, while surpluses distributed to 
annuitants bridge the gap between the insurers’ actual investment and mortality 
experiences and the projections used in pricing. Through the participation plan, systematic 
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longevity risk is shared between insurers and annuitants, as unanticipated longevity shocks 
result in benefit adjustments via the surplus mechanism. The author shows that the retiree 
draws substantial utility from access to PLAs, equivalent to 20% of initial wealth in the 
presence of systematic longevity risk. He also finds that stochasticity in mortality rates 
only has a minor impact on the appeal of PLAs to the retiree. Even if the interest rate 
guarantee is reduced to zero in adverse capital market environments, PLAs prove to 
provide substantial utility for retirees. Overall, the participating life annuity design 
produces substantial welfare gains over a no-annuity world, while being an effective setup 
that helps providers manage long-term risks that are difficult to hedge otherwise, such as 
systematic longevity risks. 
 
In “Flexible and affordable methods of paying for long-term care insurance”, Les Mayhew, 
Ben Rickayzen and David Smith argue that with the expected dramatic increase in the 
number of older people requiring care, and the tightening of public funding, individuals 
will be increasingly expected to contribute to, and plan for, their own care in later life. 
However, history shows us that people are very reluctant to save for their care to the extent 
that there are no longer any providers of traditional pre-funded long-term care insurance 
products in the U.K. to help address this problem. In this paper, the authors consider a 
product which is a disability-linked annuity that provides benefit payments towards the 
cost of both domiciliary and residential nursing care. They investigate different ways in 
which individuals can purchase this product with the goal of minimizing the impact on 
their living standards, hence making the purchase of the product more palatable. As well 
as the traditional methods of purchasing insurance out of income and savings, they show 
that this product can also be purchased by making use of assets such as residential property. 
This flexibility would allow individuals to have control over the timing of their payments 
to fit around their lifestyle, particularly those with low retirement incomes. It follows that 
some people will be more attracted to particular payment methods than others and a 
framework is presented which segments people according to individual circumstances. A 
model is developed showing how the annuity works and how premiums are calculated. 
 
In “On the structure and classification of mortality models”, Andrew Hunt and David Blake 
point out that there has recently been a huge increase in the use of models which examine 
the structure of mortality rates across the dimensions of age, period and cohort. This paper 
reviews the major developments in the field and provides a holistic analysis of these models 
and examines their similarities and differences. Specifically, it reviews the models that 
have been proposed to date, investigates the structure of age/period/cohort mortality 
models, introduces a classification scheme for existing models and lists the key principles 
a model user should consider when constructing a new model in this class. 
 
Andrew Hunt and David Blake go on to take “A Bayesian approach to modelling and 
projecting cohort effects”. They point out that one of the key motivations in the 
construction of ever more sophisticated mortality models was the realization of the 
importance of ``cohort effects’’ in the historical data. However, these are often difficult to 
estimate robustly, due to the identifiability issues present in age/period/cohort mortality 
models, and exhibit spurious features for the most recent years of birth, for which there is 
little data. These can cause problems when the model is projected into the future. In this 
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study, the authors show how to ensure that projected mortality rates from the model are 
independent of the arbitrary identifiability constraints needed to identify the cohort 
parameters. They then go on to develop a Bayesian approach for projecting the cohort 
parameters, which allows fully for uncertainty in the recent parameters due to the lack of 
information for these years of birth, which leads to more reasonable projections of 
mortality rates in future. 
 
Finally, in “Improving HMD mortality estimates with HFD fertility data”, Alexandre 
Boumezoued aims to improve mortality estimates using fertility data. Estimating the 
population exposed to risk – such as in the Human Mortality Database (HMD) – can suffer 
from errors for cohorts born in years in which births fluctuate unevenly over the year. When 
comparing period and cohort mortality tables, the author highlights the presence of 
anomalies in the period tables in the form of isolated cohort effects. His investigation of 
the HMD methodology shows that it assumes a uniform distribution of births that is 
specific to the period tables and this is likely to lead to an asymmetry with the cohort tables. 
Building on the “Phantoms Never Die” study of Cairns et al (2016) regarding the 
construction of a "data quality indicator", the author utilizes the Human Fertility Database 
(HFD) which he regards as the perfect counterpart to the HMD in terms of fertility. The 
indicator is then used to construct corrected period mortality tables for several countries, 
which the author then analyses from both an historical and prospective point of view. The 
analysis has implications for the reduction of volatility of mortality improvement rates, the 
use of cohort parameters in stochastic mortality models, and the improved fit of corrected 
tables by classical mortality models. 
 
Longevity 13 took place in Taipei, Taiwan on September 21–22, 2017. The North American 
Actuarial Journal will publish a Special Issue of selected papers presented at this 
conference. Longevity 14 will take place in Amsterdam on September 20–21, 2018. Annals 
of Actuarial Science will publish a Special Issue of selected papers presented at this 
conference.  
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